Hefei Lifeon Pharmaceutical Co., Ltd.

SZSE:003020.SZ

25.2 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q1
Operating Activities:
Net Income 47.05930.37255.29840.24664.98866.14239.05872.3851.04347.12746.88541.75841.89341.69135.45433.61637.01129.03628.20926.10325.41525.415
Depreciation & Amortization 19.26219.26213.576-18.65810.09510.09510.00110.0019.1049.10412.36712.3676.8766.8764.2064.1117.63603.773.7933.6963.696
Deferred Income Tax 000000-1.6920.82400000000000000
Stock Based Compensation 9.276024.2490000000000000000000
Change In Working Capital -84.6180-240.91-357.178357.1780-271.3163.631-163.6310-27.59964.487-64.4870-21.03717.515-19.231055.651-15.537-61.591-61.591
Accounts Receivables -107.5070-211.489-170.787170.7870-94.20385.03-85.030-29.57438.892-38.8920-37.6212.931-12.931031.55231.552-36.385-36.385
Change In Inventory 12.7210-39.493-186.391186.3910-177.09878.601-78.60101.97525.595-25.5950-0.053-9.404-6.301044.231-5.619-25.206-25.206
Change In Accounts Payables 00011.441-11.44100.3041.311-1.3110000000000000
Other Working Capital 10.168010.073-11.44111.4410-0.304-1.3111.31100000-20.98426.9190.001011.42-9.91800
Other Non Cash Items 36.193-14.889132.593337.918-394.207-10.095256.147-72.38154.527-33.111-46.885-41.758-41.893-41.691-0.5470.652-37.011-29.036-0.9090.94456.11856.118
Operating Cash Flow 63.9915.483174.3142.32938.05366.14239.05872.3851.04314.01642.33575.13133.897.34818.07755.89581.46417.05386.72115.30323.63823.638
Investing Activities:
Investments In Property Plant And Equipment -46.549-48.661-54.557-29.953-51.967-61.061-111.875-47.874-34.949-51.728-34.009-64.816-62.939-25.183-22.376-12.09-11.642-10.09-9.054-11.97-11.44-11.44
Acquisitions Net -24.448011.86-221.0950.00500.2950.0070.03100.148-0.05563.12625.16800000000
Purchases Of Investments 11.22-281.22-250-140-65-340-940.021580-140-440-1,5901,075670-69000000000
Sales Maturities Of Investments 176.7541.46399353.078500945.05237.99818001,596.2874.845-116.602120.2700000000
Other Investing Activites 188.006-279.7627.321024.898-0.001340-5201.265-0.007400.14874.945-537.939-25.1830.0030.0090-10.0900.0560.0250.025
Investing Cash Flow 115.223-328.421133.623-37.97-42.063-401.062233.45150.1316.347-491.734372.42614.97515.646-594.927-22.374-12.082-11.642-10.09-9.054-11.915-11.415-11.415
Financing Activities:
Debt Repayment 0000-41.994-41.99400000000000-240000
Common Stock Issued 000000-27.04527.04500000000000000
Common Stock Repurchased 0000000000000000000000
Dividends Paid -79.8220-61.2340-61.66000-64.8480-0.179-0.4-46.90-0.0670-27.833-0.312-0.396-0.284-10.664-10.664
Other Financing Activities -13.709-2.43563.4361.811107.11381.2725.995-3.295-67.554-3.0951.399-15.344-39.372-4.599476.808-6.814-3.735-5.6064.75821.711-15.126-15.126
Financing Cash Flow -98.862-2.435-7.9221.8113.4639.276-1.05123.75-67.554-3.0951.22-15.744-39.372-4.599476.741-6.814-31.568-29.9184.36321.426-25.79-25.79
Other Information:
Effect Of Forex Changes On Cash -00.002-0.002-0.0010.05-0.004-0.0090.140.305-0.032-0.1370.026-0.019-0.052-0.316-0.2750.1020.0010.079-0.0010.0110.011
Net Change In Cash 80.021-315.372300.221-33.831-0.5-340.189308.5966.72677.08-480.845415.84474.38810.145-592.23472.12836.72438.356-22.95382.10824.814-13.555-13.555
Cash At End Of Period 267.767187.35502.929202.708236.539237.039577.228268.638201.912124.832625.941210.097135.709125.564717.794245.666208.942170.585193.539111.43-13.555-13.555